Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
This study plans to learn more about cannabidiol (CBD) as a potential treatment in patients that have Traumatic Brain Injury (TBI)-related symptoms. CBD is a chemical found in the cannabis (or hemp) plant that can be used as a medication.
Our study is seeking individuals aged 18-60, who have been diagnosed with a traumatic brain injury (TBI).
The goal of the study is to see whether cannabinoids (CBD) can improve TBI symptoms.
Main Procedures Involved: Main study tasks include blood draws, urine pregnancy and drug screening, questionnaires, and cognitive tests.
Duration of Participation: Your participation in this study will be 12 weeks, with 12 weeks of study medication use.
18 to 60 years
1. Between the ages of 18-60 2. Diagnosed with a traumatic brain injury (TBI) 3. Interested in using cannabidiol (CBD) for TBI symptoms
Treatment
Local
220
Kent Hutchison, PhD
Protocol Number: 22-1427
More information available at ClinicalTrials.gov: NCT05632627
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers